Primary sclerosing cholangitis: Evolving concepts in diagnosis and treatment

Digestive Diseases

Volumn 15, Issue 1-2, 1997, Pages 23-41

  Harnois, Denise M ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Diagnosis; Management; Primary sclerosing cholangitis

Indexed keywords

CHOLESTASIS; CHRONIC DISEASE; HEPATIC DUCT; HUMAN; IMMUNOLOGY; INTRAHEPATIC BILE DUCT; LIVER FAILURE; LIVER TRANSPLANTATION; PATHOLOGY; PROGNOSIS; REVIEW; SCLEROSING CHOLANGITIS;

BILE DUCTS, EXTRAHEPATIC; BILE DUCTS, INTRAHEPATIC; CHOLANGITIS, SCLEROSING; CHOLESTASIS; CHRONIC DISEASE; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; PROGNOSIS;

EID: 0030628098     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000171586     Document Type: Article

References (155)

1. White TT, Hart MJ: Primary sclerosing cholangitis, Am J Surg 1987: 153:439-443.
2. United Network of Organ Sharing Update Am J Surg 1993:9:27-29.
3. Wiesncr RH: Current concepts in primary sclerosing cholangitis, Mayo Clin Proc 1994:69:969-982.
4. Wicsner RH, LaRusso NF: Clinico-pathologic features of the syndrome of primary sclerosing cholangitis, Gastroenterology 1980:79:200-206.
5. Beuers U, Spcnglcr U, Kruis W, Ay-demir U, Wiebecke B, Heldwein W, Wcinzicr M, Pape GR, Saucrhrocho T, PaumgartnerG: Ursodeoxycholic acid for treatment of primary sclerosing cholanigitis: A placebo-con-trolled trial, Hepatology 1992:16: 707-714.
6. Lo SK, Hermann R, Chapman RW, Fleming KA, Shearman J, Cusick P: Ursodeoxycholic acid in PSC: A double blind placebo controlled trial (abstract), Hepatology 1992:16:92.
7. Van Thiel DH, Wright HI, Gavalcr JS: Ursodeoxycholic acid (UDCA) therapy for primary sclerosing cholangitis (PSC): Preliminary report of a randomized controlled trial (abstract), Hepatology 1992:16:62.
8. Van Thiel DH, Carroll P, Abu-EI-niavd K, Rodriguez-Rilo H: Tacrolimus (FK506): A treatment for primary sclerosing cholangitis, Results of open label preliminary trial, Am J Gastroenterol 1994:90:455-459.
9. Knox TA, Kaplan MM: Treatment of primary sclerosing cholangitis with oral methotrexate, Am J Gastroenterol 1991:86:546-552.
10. Knox TA, Kaplan MM: A double blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis, Gastroenterology 1994; 106: 494-499.
11. Wicsner RH, Porayko MK, LaRusso NF, Ludw ig J: Primary sclerosing cholangitis: in SchifT L, Schiff ER (eds): Diseases of the liver, ed 7, Philadelphia, Lippincott, 1993, vol I, pp 411-426.
12. Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, Rolny P, Ryden BO, Tvsk C, Wallerstedt S: Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis, Gastroenterology 1991:100: 1319-1323.
13. Fausa O, Schrumpf E, Elgjo K: Relationship of inflammatory bowel disease and primary sclerosing cholangitis, Semin Liver Dis 1991:11:31-39.
14. Boden RW, Rankin JG, Gaulsten SJM: The liver in ulcerative colitis, Lancet 1959:ii:245-248.
15. Brooke BN, Dykes PW, Walter FL: A study of liver disorders in ulcerative colitis, Postgrad Med J 1961: 37:245-251.
16. Warren KW, Athanassiades S, Monge Jl: Primary sclerosing cholangitis: A study of 42 eases, Am J Surg 1966:111:23-38.
17. Eade MM, Brooke BN: Portal bacteremia in cases of ulcerative colitis submitted to colectomy, Uincct 1969:i: 1008-1009
18. Vinnik IE, Kent F Jr., Struthers JE Jr., Hill RB, Guzak S: Experimental chronic portal vein bacteremia, Proc Soc Exp Biol Med 1964:115:311-314.
19. Cangcnti JR, Wicsner RH, Beaver SJ, Ludwig I, MacCarthy RL, Do-zois RR, Zinsmcistcr AR, LaRusso NF: Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis, Gastroenterology 1989; 96:790-794.
20. Chapman RW, Arborgh BAM, Rhodes JM: Primary sclerosing cholangitis: A review of its clinical features, cholangiography and hepatic histology, Gut 1984:21:870-877.
21. Lindor KD, Wicsner RH, MacCar-thy RL, Ludwig J, LaRusso NF: Advances in primary sclerosing cholangitis, Am J Med 1990:89:73-80.
22. Siegel JH, Barnes S, Morris JS: Bile acids in liver disease associated with inflammatory bowel disease, Digestion 1977:15:469-481.
23. Hobson CH, Butt TJ, Ferry DM, Hunter J, Chadurck VS, Broom MF: Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis, Gastroenterology 1988:94:1006-1013.
24. Lichtman SN, Sartor RB, Kekec J, Schwab JH: Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth, Gastroenterology 1990:98:414-423.
25. Lichtman SN, Kcku J, Schwab JH, Sartor RB: Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline, Gastroenterology 1991:100:513-519.
26. Tracey KJ, Wei HE, Manogue KR: Cachcctin/tumor necrosis factor induces cachexia, anemia, and inflammation, J Exp Med 1988:167:1211-1227.
27. Lichtman S, Wang J, Rcinstein JL, Currin R, Lemasters JJ: Role of tumor necrosis factor in causing hepatobiliary injury in rats with experimental small bowel bacterial overgrowth, Cells Hepatic Sinusoid 1993:4:141-142.
28. Stcckman M, Drossman DA, Lc-scsnc HR: Hepatobiliary disease that precedes ulcerative colitis, J Clin Gastroenterol 1984:6:425-428.
29. Schrumpf E, Eausa O, Kolnianns-kog E, Elgio K, Ritland S, Gjone E: Sclerosing cholangitis in ulcerative colitis: A follow-up study, Scand J Gastroenterol 1982:17:33-39.
30. Stockbrugger RW, Olsson R, Jaup B, Jensen J: Forty-six patients with PSC: Radiological bile duct changes in relationship to clinical course and concomitant inflammatory bowel disease, Hepalogastroenterologv 1988:35:289-294.
31. Northover JMA, Tcrblanche J: A new look at the arterial supply of the bile duct in man and its surgical implications, Br J Surg 1979:66: 379-384.
32. Sherlock S: Pathogenesis of sclerosing cholangitis: The role of nonim-mune factors, Semin Liver Dis 1991:11:5-10.
33. Sherlock S: The syndrome of disappearing bile ducts, Lancet 1987;ii: 493-496.
34. Kemenv N, Daly I, Reiclunan B, Geller N, Botel J, Oderman P: Intra-hepatic or systemic infusion of fluorodeoxyuridinc in patients with liver metastases from colorectal cancer: A randomized trial, Ann Intern Med 1987:107:459-465.
35. Shea WJ Jr., Demas BE, Goldberg HI, Holm DC, Ferrell I D, Kerlan RK: Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: Radiographic-histologic correlation, AJR 1986:146:717-776.
36. Kemenv MM, Battifora H, Blayncy DW, Cccchi G, Goldberg DA, Lcong LA, Margolin KA, Terz JJ: Sclerosing cholangitis after continuous hepatic artery infusion of FUDR, Ann Surg 1985:202:176-181.
37. Ludwig J, Kim CH, Wiesncr RH, Krom RA: Floxuridine induced sclerosing cholangitis: An ischemic cholangiography, Hepatology 1989: 9:215-218.
38. Siegel JH, Ramsey WH: Endoscopic biliary stent for bile duct stricture after hepatic artery infusion of 5-FUDR, J Clin Gastroenterol 1986: 8:673-676.
39. Vicrling JM, Fennell R11 Jr: llisto-pathology of early and late human hepatic allograft rejection: Evidence of progressive destruction of interlobular bile ducts, Hepatology 1985:5: 1076-1082.
40. Donaldson PT, Alexander GJM, O’gradv J, Ncubergcr J, Portmann B, Thick M, Davis H, Caine RY, Williams R: Evidence of an immune response to HLA class 1 antigens in the vanishing bile duct syndrome after transplantation, Lancet 1987:1: 945-948.
41. Demetris AJ, Laskv S, Van Thiel D, Van Thiel DEL Starzl TE, Dekker A: Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosupprcsscd with cyclosporinc steroid regimen, Am J Pathol 1986:118:151-160.
42. Ludwig J, LaRusso NF, Wiesncr RH: The syndrome of primary sclerosing cholangitis, Prog Liver Dis 1990:9:555-566.
43. Finegold MJ, Carpenter RJ: Obliler-ative cholangitis due to cytomegalovirus: A possible precursor of paucity of inlrahepatic bile ducts, Hum Pathol 1982:13:662-665.
44. Ludwig J, Barham SS, LaRusso NF, Eulcback LR, Wiesncr RH, McCall JT: Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic-ulcerative colitis, Hepatology 1981: 1:632-640.
45. Mchal WZ, Hattersley AT, Chapman RW, Fleming KA: A survey of cytomegalovirus (CMV) DNA in primary sclerosing cholangitis (PSC) liver tissues using a sensitive polymerase chain reaction (PCR) based assay, J Hepatol 1992:15:396-399.
46. Keshavjce SI I, Magee LA, Mullen BJ, Baron DL, Brunton JL, Gallin-gcr S: Acaleulous cholecystitis associated with cytomegalovirus and sclerosing cholangitis in a patient with acquired immunodeficiency svndromc, Can J Surg 1993:36:321-325.
47. Phillips PA, Keast D, Papadimctrial JM, Walters MW, Stanley NF: Chronic obstructive jaundice induced by reovirus type 3 in weaning mice, Pathology 1969:1:193-203.
48. Morecki R, Glaser JH, Cho S, Balis-treri WF, Horwitz MS: Biliary' atresia and reovirus type 3 infection, N Engl J Med 1982:307:481-484.
49. Minuk GV, Rascanin N, Paul RW, Lee PW, Buchan K, Kelly JK: Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis, J Hepatol 1987:5:8-13.
50. Quigley EM, LaRusso NF, Ludwig J, MacSwcen RN, Birnie GO, Wal-kinson G: Familial occurrence of primary sclerosing cholangitis and ulcerative colitis, Gastroenterology 1983:85:1160-1165.
51. Chapman RW, Varglese Z, Gaul R, Patel G, Kokinon N, Sherlock S: Association of primary sclerosing cholangitis with HLA-B8, Gut 1983:24: 38-41.
52. Schrumpf E, Fausa O, Forrc O, Do-bloug JI1, Ritland S, Thorsbv E: I ILA antigens and immunoregulato-ry T cells in ulcerative colitis associated with hepatobiliary disease, Scand J Gastroenterol 1982:17: 187-191.
53. Shepherd HA, Selby WS, Chapman RW, Nolan D, Barbatis C, McGee JO, Jewell DP: Ulcerative colitis and persistent liver dysfunction, Q J Med 1983:52:503-513.
54. Chapman RW: Role of immune factors in the pathogenesis of primary sclerosing cholangitis, Semin Liver Dis 1991:11:1-4.
55. Prochazka EJ, Tcrasaki PI, Park MS, Goldstein LI, Busuttil RW: Association of primary sclerosing cholangitis with HLA-DRW 52a, N Engl J Med 1990:322:1842-1844.
56. Zcltergirst H, Broome U, Einarsson K, Olerup O: HLA class II gene in primary sclerosing cholangitis and chronic inflammatory bowel disease: No HLA-DRW 52a association in Swedish patients with sclerosing cholangitis, Gut 1992:33: 942-946.
57. Farraiil JM, Doherty DG, Donaldson PT, Vaughan RW, Havllar KM, Welsh KL, Eddlcston AL, Williams R: Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to protection from primary sclerosing cholangitis, Hepatology 1992; 16:390-395.
58. Donaldson PT, Farram JM, Wilkinson ML, Havllar KM, Portmann BC, Williams R: Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis, Hepatology 1991:13:129-133.
59. Chapman RW, Cottone M, Selby WS, Shepherd HA, Sherlock S, Jewell DP: Seruai autoantibodies, ulcerative colitis, and primary sclerosing cholangitis, Gut 1986:27:86-91.
60. Zauli D, SchrumpfE, Crespi C, Cas-sani F, Gausa O, Aadland E: An autoantibody profile in primary sclerosing cholangitis, J Hepatol 1987:5:14-17.
61. Mieli-Vergani G, Lobo-Yeo A, McFarlanc BM, McFarlane IG, Mo wat AP, Vergani D: Different immune mechanisms leading to auto-immunity in primary sclerosing cholangitis and autoimmune chronic hepatitis of childhood, Hepatology 1989;9:198-203.
62. Das KM, Vecchi M, Sakamakis S: A shared and unique epitope on human colon, skin, and biliary epithelium detected by monoclonal antibody, Gastroenterology 1990:98: 464-469.
63. Ducrr RH, I'argan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, Shanahan F: Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis, Gastroenterology 1991:100:1385-1391.
64. Klein R, Eiscnburg J, Weber P, Sci-bold F, Berg PA: Significance and specificity of antibodies to neutrophils detected by Western blotting for the serological diagnosis of primary sclerosing cholangitis, I Icpato logy 1991:14:1147-1152.
65. Scibold F, Weber P, Klein R, Berg PA, Wiedemann KH: Clinical significance of antibodies against neutrophils in patients with IBD and primary sclerosing cholangitis, Gut 1992:33:657-662.
66. Char MJ, Lee SL, Chen TY, Tsay GJ: Specificity of antinuclear antibodies in primary biliary cirrhosis, Ann Rheum Dis 1995:54:148-151.
67. Brinch L, Teisbcrg P, Schrumpf E, Akcsson I: The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis, Scand J Gastroenterol 1982; 17:5233-5237.
68. Sanaldi G, Donaldson PT, Senaldi G, Magrin S, Farrnat JM, Alexander GJ, Vergani D, Williams R: Activation of the complement system in primary sclerosing cholangitis, Gas-t roenle rologv 1989:97:1430-1434.
69. Lindor KD, Wiesner RH, Kalz-mann JA, LaRusso NF, Beaver SJ: Lymphocyte subsets in primary sclerosis cholangitis, Dig Dis Sci 1987: 32:720-725.
70. Hashimoto E, Lindor KD, Hamburger HA, Dickson ER, Czaja AJ, Wiesner RH, Ludwig J; Immunohis-tochcmical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with sclerosing cholangitis and autoimmune chronic active hepatitis, Mayo Clin Proc 1993;68:1049-1055.
71. Chapman RW, Kelly PM, Heryct A, Jewell DP, Fleming KA: Expressions of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis, Gut 1988.29:422-427.
72. Broome U, Glaumann II, Hult-crantz R, Forsurn U: Distribution of HLA-DR, HLA-DPnt, HLA-DQ antigens in liver tissue from patients with primary' sclerosing cholangitis, Scand J Gastroenterol 1990:25:54-58.
73. Lindor KD, Wiesner RH, LaRusso NF, Hamburger HA: Enhanced autoreactivity of T-lvmphocvtes in primary sclerosing cholangitis, Ilepato logy 1987; 7:884-888.
74. Ueno Y, LaRusso NF: Primary sclerosing cholangitis, J Gastroenterol 1994:29:531-543.
75. Wiesner RH, Ludwig J, LaRusso NF, Dickson ER: Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis, Gastroenterology 1985:95:1395-1398.
76. Gross JB Jr., Ludwig J, Wiesner RH, MeCall J'f, LaRusso NF: Abnormalities in tests of copper metabolism in primary sclerosing cholangitis, Gastroenterology 1985:89:272-278.
77. MacCarthy RL, LaRusso NF, Wiesner R11, Ludwig J: Primary sclerosing cholangitis: Findings on cholangiography and pancreatography, Radiology 1983:149:39-44.
78. Epstein O, Chapman RWG, Lake-Bakaar G, Foo AV, Rosalki SB, Sherlock S: The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis, Gastroenterology 1982:83:1177-1182.
79. Ludwig J: Surgical pathology of the syndrome of primary sclerosing cholangitis, Am J Surg Pathol 1989; 13(suppl 1):43-49.
80. Ludwig J: Small duct primary sclerosing cholangitis, Semin Liver Dis 1991:11:11-17.
81. Rosen CB, Nagomey DM: Cholan-giocarcinoma complicating primary sclerosing cholangitis, Semin Liver Dis 1991:11:26-30.
82. Stcinhart AI I, Simons M, Stone R, Heathcote J: Multiple hepatic abscesses: Cholangiographic changes simulating sclerosing cholangitis and resolution after percutaneous drainage, Am J Gastroenterol 1990: 85:306-308.
83. Bucuvalas JC, Bove KE, Kaufman RA, Gilchrist MJR, Oldham KT, Balistri WF: Cholangitis associated with Cryptococcus neoformans, Gastroenterology 1985:88:1055-1059.
84. Chan JC, Jeffers U, Gaud EW, Hutson D, Martinez DV, Reddy KR, Hasson F, Schiff ER: Visceral proto thccosis mimicking sclerosing cholangitis in an immunocompetent host successful amifungal therapy, Rev Infect Dis 1990;12:802-807.
85. Patel SA, Borges MC, Batt MD, Ro-senblatc H J: T richosporon cholangitis associated with hyperbilirubin and findings suggesting primary sclerosing cholangitis on endoscopic retrograde cholangiopancreatography, Am J Gastroenterol 1990:85: 84-87.
86. Margulis SJ, Honig CL, Soave R, Govoni AF, Mouradian JA, Jacobson IM: Biliary tract obstruction in the acquired immunodeficiency syndrome, Ann Intern Med 1986: 105:207-210.
87. Schneidcrman DJ, Cello JP, Laing FC: Papillary stenosis and sclerosing cholangitis in acquired immunodeficiency syndrome, Ann Intern Med 1987:106:546-549.
88. Dowsett JF, Miller A, Davidson R, Vaira D, Polydori A, Cairns SR, Weller IV: Sclerosing cholangitis in acquired immunodeficiency syndrome, ScandJ Gastroenterol 1988: 23:1267-1274.
89. Cello JP: Acquired immunodeficiency syndrome cholangiopathy spectrum of disease, Am J Med 1989;86:539-546.
90. Thompson HH, Pitt H A, Lewis KJ, Longmire WP Jr.: Sclerosing cholangitis and histocytosis, Gut 1984:25: 526-530.
91. Thompson HH, Pitt HA, Tompkins RK, Longmire WP: Primary sclerosing cholangitis: A heterogenous disease, Ann Surg 1982,196:127-136.
92. Sokal EM, dcGoyet J, But JP, Ha-bets S, Cosseye S, Clapuyt P, Claus D, Otte JB: Unifocal stricture of the common bile duct in two children: A localized form of primary sclerosing cholangitis, J Pediatr Gastroenterol Nutr 1990:11:268-274.
93. Graham SM, Barusck K, Cahou CE, Baker CC: Cholangitis glandularis proliferans: A histologic variant of primary sclerosing cholangitis with distinctive clinical and pathological features, J Clin Gastroenterol 1988; 10:579-583.
94. Rosengart TK, Rotterdam H, Ran-son HC: Eosinophilic cholangitis: A self-limited cause of extrahcpalic biliary obstruction, Am J Gastroenterol 1990:85:582-585.
95. Platt ML, Kiesling VJ Jr., Vaccaro JA: Eosinophilic ureteritis associated with eosinophilic cholangitis: A case report, J Urol 1990; 144:127-129.
96. Ludwig J, Wicsner RH, LaRusso NF: Idiopathic adulthood ducto-pcnia: A cause of chronic liver disease and biliary cirrhosis, J Hepatol 1988:7:193-199.
97. Wicsner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarthv RL, Hunter EB: PSC: Natural history, prognostic factors and survival analysis, Hepatology 1989:10: 430-436.
98. Helzbcrg JH, Petersen JM, Boyer JL: Improved survival with primary sclerosing cholangitis: A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients, Gastroenterology 1987:92:1869-1875.
99. Aadland E, Schrumpf E, Fausa O, Elgjo K, Hcilo A, Aakhus T: Primary sclerosing cholangitis: A long-term follow-up study, Scand J Gastroenterol 1987;22:655-664.
100. Dickson ER, Mutaugh PA, Wies-ner RH, Grambsch PM, Fleming TR, Ludwig J: Primary sclerosing cholangitis: Refinement and validation of survival models, Gastroenterology 1992:103:1893-1901.
101. Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmarm BC, Westabv D, Williams R: Natural history and prognostic variables in primary sclerosing cholangitis, Gastroenterology 1991:100:1710-1717.
102. Lee Y-M, Kaplan MM: Primary sclerosing cholangitis, N Engl J Med 1995:332:924-933.
103. LaRusso NF, Wiesner RH, Ludwig J, MacCarthv RL, Beaver SJ, Zinsmeistcr AR: Prospective trial of penicillamine in primary sclerosing cholangitis, Gastroenterology 1988:95:1036-1042.
104. Allison MC, Burrough AK, Noone P, Summcrficld JA: Biliary lavage with corticosteroids in PSC: A clinical Cholangiographie and bacteriological study, J Hepatol 1986; 3:118-122.
105. Bürgert SL, Brown BP, Kirkpatrick RB, LaBrccque DR: Positive corticosteroid response in early primary sclerosing cholangitis (abstract), Gastroenterology 1984:86: 1037.
106. Lindor KD, Wiesner RH, Colwell L„ Steiner B, Beavers S, LaRusso NF: The combination of prednisone and colchicine in patients with primary sclerosing cholangitis, Am J Gastroenterol 1991:86: 57-61.
107. Hay JE, Lindor KD, Wiesner RH, Dickson ER, Kroni RA, LaRusso NF: The metabolic bone disease of primary sclerosing cholangit is, Hepatology 1991:14:257-261.
108. Javett SL: Azathioprine in primary sclerosing cholangitis, Lancet 1971:i:810.
109. Wagner A: Azathioprine treatment in primary sclerosing cholangitis, Lancet 1971;ii:663-664.
110. Kaplan MM: Medical approaches to primary sclerosing cholangitis, Semin Liver Dis 1991:11:56-63.
111. Wiesner RH, Steiner B, LaRusso NF, Lindor KD, Baldus WP: A controlled clinical trial evaluating cyclosporine in the treatment of primary sclerosing cholangitis (abstract), Hepatology 1991:14 (suppl):63.
112. Bergasa NV, Jones EA: The pruritus of cholestasis, Semin Liver Dis 1993:13:319-327.
113. Thornton JR, Losowsky MS: Opioid peptides and primary biliary cirrhosis, BMJ 1988:297:1510-1514.
114. Datta DV, Sherlock S: Cholestyramine for long-term relief of the pruritus complicating intrahepatic cholestasis, Gastroenterology 1966;50:323-332.
115. Lloyd-Thomas H, Sherlock S: Tes-tosteronc therapy for the pruritus of obstructive jaundice: Br Med J 1952;ii: 1289-1291.
116. Raderee M, Miller C, Schelthauer W: Ondansetron for pruritus due to cholestasis, N Engl J Med 1994: 330:1540.
117. Calmus Y, Gane P, Rouger P, Pau-pon R: Hepatic expression of classi and II major histocompatibility complex molecules in primary biliary cirrhosis: EITcct of ursodeoxycholic acid, Hepatologv 1990:11:12-15.
118. Hanid MA, Levi AJ: Phototherapy for pruritus in primary biliary cirrhosis, Lancet 1980:ii:530.
119. Almasio P, Bortolini M, Pagliaro L, Coltorti M: Role of 5-adenosyl-L-methioninc in the treatment of intrahepatic cholestasis, Drugs 1990:40:111-123.
120. Bloomer JR, Boyer JL: Phenobar-bital effects in cholestatic liver diseases, Ann Intern Med 1975:82: 310-317.
121. Baehs L, Parcs A, Elena M, Piera C, Rodes J: Comparison of rifampin with phenobarbitone for treatment of pruritus in biliary cirrhosis, Lancet 1989:1:574-576.
122. Podestà A, Lopez P, Terg R, Vil-lamil F, Flores D, Mastai R, UdaondoCB, Compatte JP: Treatment of pruritus of primary cirrhosis with rifampin, Dig Dis Sci 1991;36:216-220.
123. Cohen LB, Antbinder EP, Wolke AM, Field SP, Schafl'ncr F: Role of plasmapheresis in primary biliary cirrhosis, Gut 1985:26:291-294.
124. Bergasa NV, Talbot TL, Ailing DW, Schmitt JM, Walker EC, Baker BL, Korcnntan JC, Park V, Hoofnaglc JM, Jones EA: A controlled trial of naloxone infusions for the pruritus of chronic cholestasis, Gastroenterology 1992:102: 544-549.
125. Lanspa SJ, Chan AT, Bel! JS III, Go VL, Dickson ER, DiMagno EP: Pathogenesis of steatorrhea in primary biliary cirrhosis, Hepalo-logy 1985:5:837-842.
126. Hay JF., Wiesner RH, Shorter RG, LaRusso NF, Baldus WP: Primary sclerosing cholangitis and celiac disease: A novel association, Ann Intern Med 1988:109:713-717.
127. Borkjc B, Vctvik K, Gdegaard S, Schrumpf E, Larsscn TB, Kol-manskog E: Chronic pancreatitis in patients with sclerosing cholangitis and ulcerative colitis, Scand J Gastroenterol 1985:20:539-542.
128. Epstein O, Chapman RW, Lakc-Bakaar G, Foo AY, Rosaiki SB, Sherlock S: The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis, Gastroenterology 1982:83:1 177-1182.
129. Sartin JS, Wiesner RH, LaRusso NF: Fat-soluble vitamin deficiencies in primary sclerosing cholangitis (abstract), Gastroenterology 1987:92:1615.
130. Jorgensen RA, Lindor KD, Sartin JS, LaRusso NF, Wiesner RH: Scrum lipid and fat soluble vitamin levels in primary sclerosing cholangitis, J Clin Gastroenterol 1995; 20:215-219.
131. Munoz SJ, Heubi J, Deems R, Ross R, Maddrcv WC: Vitamin I and E deficiency in primary sclerosing cholangitis: Mechanism, frequency, and relation to deficiency in other lipid soluble vitamins (abstract), Gastroenterology 1991:100:539.
132. Gaing AA, Geders JM, Cohen SA, Siegel JH: Endoscopic management of primary sclerosing cholangitis: Review and report of an open series, Am J Gastroenterol 1993: 88:2000-2008.
133. Cotton PB, Nicki N: Endoscopic and radiologic approaches to therapy in primary sclerosing cholangi-tis, Semin Liver Dis 1991:11:40-48.
134. Johnson GK, Gecncn JE, Venu RP, Schmalz MJ, Hogan WJ: Endoscopic treatment of biliary strictures in sclerosing cholanigitis: A larger series and recommendations for treatment, Gastrointest Endosc 1991:37:38-43.
135. Brandt DJ, MacCarthy RL, Char-boncau JW, LaRusso NF, Wiesner RH, Ludwig J; Gallbladder disease in patients with primary' sclerosing cholangitis, A J R 1988:150:571-574.
136. Skolkin MD, Ais Paugh JP, Casarella WJ, Chuang UP, Gaambos JT: Sclerosing cholangitis: Palliation with percutaneous cholangio-plasty, Radiology 1989:170:199-206.
137. Bender CE, Wiesner RH, LeRoy AJ, LaRusso NF, Nagorney DM: Long-term benefit of percutaneous dilatation of dominant bile duct strictures in primary sclerosing cholanigitis (abstract), Hepatology 1991:14:191.
138. Kuwayti K, Baggenstoss AH, Stauffer MH, Priestly JT: Carcinoma of the major intrahepatic and extrahepatic bile ducts exclusive of papilla of Valer, Surg Gynecol Ob-stet 1957;104:357-366.
139. Rosen CB, Nagorney DM, Wies-ncr RII, Coffey RJ Jr., LaRusso NF: Cholangiocarcinonta complicating primary sclerosing cholangitis, Ann Surg 1991:213:21-25.
140. Miros M, Kcrline P, Walker N, Harder J, Lynch S, Strong R: Predicting cholangiocarcinonta in patients with primary sclerosing cholangitis before transplantation, Gut 1991:32:1369-1373.
141. Fausa O, Schrumpf E: Cholangio-carcinonta occurs with high frequency in primary sclerosing cholangitis (abstract), Scand J Gastroenterol 1989:24:59.
142. Boerma FJ: Research into the results of resection of hilar bile duct cancer, Surgery 1990; 108:572-580.
143. Nagomev DM, Donohue JH, Far-nell MB: Outcomes after curative resections of cholangiocarcinonta, Arch Surg 1993:128:871-879.
144. Pichlmayr R, Lantesch P, Wei-ntann A, Tusch G, Ringe B: Surgical treatment of cholangioccllular carcinoma, World J Surg 1995; 19: 83-88.
145. Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Rilts RE Jr.: Diagnostic role of serum CA 19-9 for cholangiocarcino-nta in patients with primary sclerosing cholangitis, Mayo Clin Proc 1993:68:874-879.
146. Fisher A, Tlteise N D, Min A, Eytori M, Sukra E, Pearl A, Schwartz M, Miller C, Sheiner P: CA 19-9 docs not predict cholangiocarcino-nta in patients with primary sclerosing cholangitis undergoing liver transplantation, Liver Transplant Surg 1985; 1:94-98.
147. Stieber AC, Marino IR, Iwatsuki S, Starzl TE: Cholangiocarcinonta in sclerosing cholangitis: The role of liver transplantation, Int Surg 1989:74:1-3.
148. Conn HO: Transjugular intrahepatic portal systemic shunts: The state of the art, Hepatology 1993: 17:148-158.
149. Wiesner RH, LaRusso NF, Dozois RR, Beaver SJ: Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis, Gastroenterology 1986:90: 316-322.
150. Kartheuscr AH, Dozois RR, Wiesner RH, LaRusso NF, listrup DM, Sehlcck CD: Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis, Ann Surg 1993: 217:314-320.
151. McEntee G, Wiesner RH, Rosen C, Cooper J, Wahlstrom E: A comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis, Transplant Proc 1991:23:1563-1564.
152. Hunter EB, Wiesner RH, MacCar-thy RL, et al: Docs primary sclerosing cholangitis recur after liver transplantation? (Abstract.) Gastroenterology 1989:96:610.
153. Sheng R, Zajko AB, Campbell WL, Abu-Elntagd K: Biliary strictures in hepatic transplants: Prevalence and types in patients with primary sclerosing cholangitis vs those w ith other liver diseases, AJR 1993; 161:297-300.
154. Gavalcr JS, Delemos B, Belle SH, Hcyl AE, Tarter RE, Starzl TE, Gavalcr C, Van Thiel DH: Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis, Dig Dis Sci 1991:36:321-328.
155. Higashi II, Vanaga K, Marsh JW: Developments of colon cancer after livcrtransplantaiion in primary sclerosing cholanigitis associated with ulcerative colitis, Hepatology 1990:11:477-480.